Tenaya Therapeutics Statistics
Total Valuation
TNYA has a market cap or net worth of $190.12 million. The enterprise value is $106.39 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TNYA has 78.89 million shares outstanding. The number of shares has increased by 29.65% in one year.
Shares Outstanding | 78.89M |
Shares Change (YoY) | +29.65% |
Shares Change (QoQ) | +5.83% |
Owned by Insiders (%) | 1.18% |
Owned by Institutions (%) | 43.10% |
Float | 54.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.42 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.28, with a Debt / Equity ratio of 0.12.
Current Ratio | 6.28 |
Quick Ratio | 5.94 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.54% and return on invested capital (ROIC) is -45.00%.
Return on Equity (ROE) | -74.54% |
Return on Assets (ROA) | -41.33% |
Return on Capital (ROIC) | -45.00% |
Revenue Per Employee | n/a |
Profits Per Employee | -$862,407 |
Employee Count | 140 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.11% in the last 52 weeks. The beta is 2.35, so TNYA's price volatility has been higher than the market average.
Beta (5Y) | 2.35 |
52-Week Price Change | +7.11% |
50-Day Moving Average | 2.07 |
200-Day Moving Average | 3.70 |
Relative Strength Index (RSI) | 63.61 |
Average Volume (20 Days) | 2,442,235 |
Short Selling Information
The latest short interest is 4.88 million, so 6.18% of the outstanding shares have been sold short.
Short Interest | 4.88M |
Short Previous Month | 5.08M |
Short % of Shares Out | 6.18% |
Short % of Float | 9.00% |
Short Ratio (days to cover) | 9.77 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -126.95M |
Pretax Income | -120.74M |
Net Income | -120.74M |
EBITDA | -118.31M |
EBIT | -126.95M |
Earnings Per Share (EPS) | -$1.53 |
Full Income Statement Balance Sheet
The company has $99.30 million in cash and $15.57 million in debt, giving a net cash position of $83.73 million or $1.06 per share.
Cash & Cash Equivalents | 99.30M |
Total Debt | 15.57M |
Net Cash | 83.73M |
Net Cash Per Share | $1.06 |
Equity (Book Value) | 134.00M |
Book Value Per Share | 1.70 |
Working Capital | 88.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$97.84 million and capital expenditures -$1.04 million, giving a free cash flow of -$98.88 million.
Operating Cash Flow | -97.84M |
Capital Expenditures | -1.04M |
Free Cash Flow | -98.88M |
FCF Per Share | -$1.25 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |